Physician profile
John Logan Sobiesk
NPI 1538797410
$3,268.66
in general payments reported to CMS, 2019-2025
9 companies · $2,858 in 2025
The $2,858 reported for 2025 was more than what 93% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $115 · 2023: $128 · 2024: $167 · 2025: $2,858.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,600 · Food and Beverage: $1,046 · Honoraria: $507.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,600.04 |
| Food and Beverage | $1,046.32 |
| Honoraria | $507.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,186.23 | 2025 | Inspire |
| Ambu A/S | $507.00 | 2025 | |
| Stryker Corporation | $285.92 | 2022-2024 | Xpress Ent Dilation System, Scopis Ent, Smartlock |
| Regeneron Healthcare Solutions, INC. | $125.00 | 2024 | Libtayo |
| Integra Lifesciences Corporation | $63.04 | 2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Astrazeneca Pharmaceuticals LP | $49.08 | 2025 | Tezspire |
| Amgen INC. | $24.97 | 2025 | Tezspire |
| Glaxosmithkline, LLC. | $15.49 | 2025 | Nucala |
| Medtronic, INC. | $11.93 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Sobiesk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.